Debray, F.-G., WEEKERS, L., Dadoumont, C., Grandjean, C., DEBERG, M., Boemer, F., & Bours, V. (2020). Actualités thérapeutiques dans les erreurs innées du métabolisme. Revue Médicale de Liège, 75 (5-6), 420-425. |
Henrotin, Y., Gharbi, M., DEBERG, M., & De Pauw, E. (20 January 2016). Biomarker for osteoarthritis and use thereof. |
BOEMER, F., DEBERG, M., SCHOOS, R., CABERG, J.-H., GAILLEZ, S., Dugauquier, C., Delbecque, K., François, A., Maton, P., Demonceau, N., Senterre, G., Ferdinandusse, S., & DEBRAY, F.-G. (2016). Diagnostic pitfall in antenatal manifestations of CPT II deficiency. Clinical Genetics. doi:10.1111/cge.12593 |
BOEMER, F., DEBERG, M., SCHOOS, R., Baise, E., Amory, H., Gault, G., Carlier, J., Gaillard, Y., Marcillaud-Pitel, C., & Votion, D. (2015). Quantification of hypoglycin A in serum using aTRAQ((R)) assay. Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 997, 75-80. doi:10.1016/j.jchromb.2015.06.004 |
BOEMER, F., SCHOOS, R., & DEBERG, M. (2015). Quantification of physiological aminoacids using aTRAQ kit: evaluation and implementation of new markers. Annales de Biologie Clinique, 73 (4), 427-442. doi:10.1684/abc.2015.1066 |
Henrotin, Y., Gharbi, M., DEBERG, M., & De Pauw, E. (08 July 2014). Biomarker for osteoarthritis and/or other ageing-related diseases, and use thereof. |
Henrotin, Y., Chevalier, X., DEBERG, M., Balblanc, J. C., Richette, P., Mulleman, D., Maillet, B., Rannou, F., Piroth, C., Mathieu, P., & Conrozier, T. (2013). Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1 NO(2) ) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis: a research study part of the Biovisco study. Journal of Orthopaedic Research, 31 (6), 901-7. doi:10.1002/jor.22297 |
Henrotin, Y., Kraus, V., Huebner, J., Helleputte, T., & DEBERG, M. (2013). Baseline measurements of COLL2-1 and COLL2-1 NO2 in urine are highly predictive of joint space narrowing in knee osteoarthritis. Annals of the Rheumatic Diseases. |
Henrotin, Y., Labasse, A., Franck, T., Bosseloir, A., Bury, T., & DEBERG, M. (2013). Collagen catabolism through Coll2-1 and Coll2-1NO and myeloperoxidase activity in marathon runners. SpringerPlus, 2 (1), 92. doi:10.1186/2193-1801-2-92 |
REGINSTER, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (11 December 2012). Detection of specific nitrated markers. |
Henrotin, Y., Gharbi, M., Mazzucchelli, G., Dubuc, J.-E., De Pauw, E., & DEBERG, M. (2012). Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis. Arthritis and Rheumatism, 64 (7), 2260-7. doi:10.1002/art.34392 |
Henrotin, Y., Kraus, V., Brandt, K., Mazzuca, S., Huebner, J., Boulanger, B., & DEBERG, M. (2012). Measurement of urinary Coll2-1NO2 is predictif of joint space narrowing in knee osteoarthritis. Osteoarthritis and Cartilage, 20 (Suppl 1), 80. |
Henrotin, Y., Martel-Pelletier, J., Msika, P., Guillou, G. B., & DEBERG, M. (2012). Usefulness of specific OA biomarkers, Coll2-1 and Coll2-1NO(2), in the anterior cruciate ligament OA canine model. Osteoarthritis and Cartilage, 20 (7), 787-90. doi:10.1016/j.joca.2012.03.016 |
Punzi, L., Ramonda, R., DEBERG, M., Frallonardo, P., Campana, C., Musacchio, E., & Henrotin, Y. (2012). Coll2-1, Coll2-1NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis and Cartilage, 20 (6), 557-61. doi:10.1016/j.joca.2012.02.638 |
Reginster, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (29 March 2011). Detection of specific nitrated markers. |
Gharbi, M., Deberg, M., & Henrotin, Y. (2011). Application for proteomic techniques in studying osteoarthritis: a review. Frontiers in Physiology, 2 (90), 4-14. doi:10.3389/fphys.2011.00090 |
Gharbi, M., Dubuc, J., Deberg, M., De Pauw, E., & Henrotin, Y. (2011). Fibulin-3 fragments (FIB3-1 and FIB3-2) are potential new biomarkers for the diagnosis of osteoarthritis. Annals of the Rheumatic Diseases, 70 (Suppl 3), 354. |
Henrotin, Y., Conrozier, T., DEBERG, M., Walliser-Lohse, A., Richette, P., Mulleman, D., Maillet, B., Rannou, F., Piroth, C., Hilliquin, P., Vignon, E., & Chevalier, X. (2011). Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis. Annals of the Rheumatic Diseases, 70 (Suppl 3), 214. |
Henrotin, Y., Kraus, V., Brandt, K. D., Mazzuca, S. A., Huebner, J., Boulanger, B., & DEBERG, M. (2011). Measurements of urinary COLL2-1NO2 is predictif of joint space narrowing in knee osteoarthritis. Osteoarthritis and Cartilage. |
Rego-Perez, I., Fernandez-Moreno, M., Deberg, M., Pertega, S., Fernandez-Lopez, C., Oreiro, N., Henrotin, Y., & Blanco, F. J. (2011). Mitochondrial DNA haplogroups and serum levels of proteolytic enzymes in patients with osteoarthritis. Annals of the Rheumatic Diseases, 70 (4), 646-52. doi:10.1136/ard.2010.133637 |
Verwilghen, D., Martens, A., Busschers, E., Franck, T., Deberg, M., Henrotin, Y., Vander Heyden, L., & Serteyn, D. (2011). Coll2-1, Coll2-1NO2 and myeloperoxidase concentrations in the synovial fluid of equine tarsocrural joints affected with osteochondrosis. Veterinary Research Communications, 35 (7), 401-8. doi:10.1007/s11259-011-9487-5 |
Reginster, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (01 June 2010). Method for monitoring collagen type II degradation in cartilage. |
Henrotin, Y., & DEBERG, M. (2010). Les marqueurs biologiques du collagène de type II. De nouveaux outils d'évaluation de l'arthrose. Ortho-Rhumato, 8 (6), 226-230. |
Henrotin, Y., & Deberg, M. (2010). De nouveaux outils d’évaluation de l’arthrose. Ortho-Rhumato, 8, 1-5. |
Huebner, J. L., Williams, J. M., Deberg, M., Henrotin, Y., & Kraus, V. B. (2010). Collagen fibril disruption occurs early in primary guinea pig knee osteoarthritis. Osteoarthritis and Cartilage, 18 (3), 397-405. doi:10.1016/j.joca.2009.09.011 |
Rego-Perez, I., Fernadez-Moreno, M., DEBERG, M., Pertega, S., Fernandez-Lopes, C., Oreiro, N., Acasuso, M., Bonome-Gonzalez, V., Henrotin, Y., & Blanco, F. (2010). The mitochondria-related phenotype in the osteoarthritis disease. Osteoarthritis and Cartilage. |
Rego-Perez, I., Fernandez-Moreno, M., Deberg, M., Pertega, S., Fenandez-Lopez, C., Oreiro, N., Henrotin, Y., & Blanco, F. J. (2010). Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Annals of the Rheumatic Diseases, 69 (5), 910-7. doi:10.1136/ard.2009.117416 |
Rego-Perez, I., Fernandez-Moreno, M., DEBERG, M., Pertega, S., Fernandes-Lopez, C., Oreiro, N., Acasuso, M., Henrotin, Y., & Blanco, F. (2010). MtDNA haplogroups define two phenotypes of osteoarthritis. Arthritis and Rheumatism, 62, 348. |
Richette, P., Eymard, C., Deberg, M., Vidaud, D., de Kerguenec, C., Valla, D., Vicaut, E., Bardin, T., & Henrotin, Y. (2010). Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis. Rheumatology, 49 (4), 760-6. doi:10.1093/rheumatology/kep429 |
Kesteloot, F., Pelletier, J.-P., Martel-Pelletier, J., Caron, J., Boileau, C., Bosseloir, A., Msika, P., Guillou, B., Henrotin, Y., & Deberg, M. (23 May 2009). Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxydase in dogs after transection of the cruciate ligament of the knee [Poster presentation]. ICRS 2009, Miami, United States. |
Gharbi, M., DEBERG, M., Dubuc, J., De Pauw, E., & Henrotin, Y. (2009). Identification of novel biological markers of osteoarthritis by proteomic approach. Osteoarthritis and Cartilage, 17 (Suppl 1), 74. |
Henrotin, Y., Deberg, M., Mathy, M., & Deby-Dupont, G. (2009). Biochemical biomarkers of oxidative collagen damage. Advances in Clinical Chemistry, 49, 31-55. doi:10.1016/S0065-2423(09)49002-4 |
Rego, I., Fernandez, M., DEBERG, M., Pertega, S., Oreiro, N., Galdo, F., Henrotin, Y., & Blanco, F. (2009). Mitochondrial DNA haplogroups modulate the serum levels of biomarkers in patients with osteoarthritis. Osteoarthritis and Cartilage, 17 (Suppl 1), 72. |
Richette, P., Eymard, C., DEBERG, M., Vidaud, D., Bardin, T., & Henrotin, Y. (2009). Effects of iron depletion on articular biomarkers and joint symptoms in patients with genetic hemochromatosis: a prospective, longitudinal study. Osteoarthritis and Cartilage, 17 (Suppl 1), 75. |
Verwilghen, D., Busoni, V., Gangl, M., Franck, T., Lejeune, J.-P., Vander Heyden, L., Detilleux, J., Grulke, S., Deberg, M., Henrotin, Y., & Serteyn, D. (2009). Relationship between biochemical markers and radiographic scores in the evaluation of the osteoarticular status of Warmblood stallions. Research in Veterinary Science, 87 (2), 319-28. doi:10.1016/j.rvsc.2009.02.002 |
REGINSTER, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (12 August 2008). Method for monitoring collagen type II degradation in cartilage. |
REGINSTER, J.-Y., DEBERG, M., Henrotin, Y., & Christgau, S. (01 July 2008). Detection of specific nitrated markers. |
Deberg, M., Dubuc, J. E., Labasse, A., Sanchez, C., Quettier, E., Bosseloir, A., Crielaard, J.-M., & Henrotin, Y. (February 2008). One-Year Follow-up of Coll2-1, Coll2-1no2 and Myeloperoxydase Serum Levels in Osteoarthritis Patients after Hip or Knee Replacement. Annals of the Rheumatic Diseases, 67 (2), 168-74. doi:10.1136/ard.2007.073452 |
Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., Delcour, J.-P., Crielaard, J.-M., & Henrotin, Y. (February 2008). Phenotypic Characterization of Osteoblasts from the Sclerotic Zones of Osteoarthritic Subchondral Bone. Arthritis and Rheumatism, 58 (2), 442-55. doi:10.1002/art.23159 |
Henrotin, Y., Pelletier, J., Martel-Pelletier, J., Caron, J., Boileau, Bosseloir, A., Msika, P., Guillou, B., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1 NO2 and myeloperoxidase in dog after transection of the cruciate ligament of the knee. Arthritis and Rheumatism, 58 (Suppl 9), 652. |
Henrotin, Y., Pelletier, J., Martel-Pelletier, J., Caron, J., Boileau, C., Bosseloir, A., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1 NO2 and myeloperoxidase in dog after transection of the cruciate ligament of the knee. Annals of the Rheumatic Diseases, 67 (Suppl.2), 593. |
Henrotin, Y., Pelletier, J., Martel-Pelletier, J., Caron, J., Boileau, C., Bosseloir, A., Msika, P., Guillou, B., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1 NO2 and myeloperoxidase in dog after transection of the cruciate ligament of the knee. Osteoarthritis and Cartilage, 16 (Suppl 4), 51. |
Henrotin, Y., Pelletier, P., Martel-Pelletier, J., Caron, C., Boileau, A., Bosseloir, P., Msika, B., Guillou, B., & DEBERG, M. (2008). Follow-up of Coll2-1, Coll2-1NO2 and myeloperoxydase in dogs after transaction of the cruciate ligament of the knee. Osteoarthritis and Cartilage. |
Ramonda, R., DEBERG, M., Campana, C., Frigato, M., Bosseloir, A., Henrotin, Y., & Punzi, L. (2008). Coll2-1, Coll2-1 NO2 and myeloperoxidase serum levels in erosive and non-erosive osteoarthritis of the hands. Osteoarthritis and Cartilage, 16 (Suppl 4), 56. |
Sanchez, C., Deberg, M., Msika, P., Baudouin, C., & Henrotin, Y. (2008). Study of the in vitro conditions promoting hypertrophic differentiation of osteoarthritic articular chondrocytes [Poster presentation]. 28th European Workshop for Rheumatology Research, Paris, France. |
Ameye, L. G., Deberg, M., Oliveira, M., Labasse, A., Aeschlimann, J. M., & Henrotin, Y. (October 2007). The chemical biomarkers C2C, Coll2-1, and Coll2-1NO(2) provide complementary information on type II collagen catabolism in healthy and osteoarthritic mice. Arthritis and Rheumatism, 56 (10), 3336-3346. doi:10.1002/art.22875 |
Lejeune, J.-P., Serteyn, D., Gangl, M., Schneider, N., Deby-Dupont, G., Deberg, M., & Henrotin, Y. (July 2007). Plasma concentrations of a type II collagen-derived peptide and its nitrated form in growing ardenner sound horses and in horses suffering from juvenile digital degenerative osteoarthropathy. Veterinary Research Communications, 31 (5), 591-601. doi:10.1007/s11259-007-3518-2 |
Deberg, M., Labasse, A., Sanchez, C., Bosseloir, A., & Henrotin, Y. (2007). Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxidase serum levels in marathon runners. Osteoarthritis and Cartilage, 15 (Suppl C), 67. |
Deberg, M., Labasse, A., Sanchez, C., Bosseloir, A., & Henrotin, Y. (2007). Follow-up of COLL2-1, COLL2-1NO2 and myeloperoxidase serum levels in marathon runners [Poster presentation]. 12th World Congress of the OsteoArthritis Research Society International (OARSI), Fort Lauderdale, United States - Florida. |
Deberg, M., Labasse, A., Sanchez, C., Bosseloir, A., & Henrotin, Y. (2007). Etude des variations de marqueurs de la degradation du cartilage et de l’activation des neutrophiles après un marathon. Revue du Rhumatisme, 74 (10-11), 1088-1089. |
Gangl, M., Deberg, M., Lejeune, J.-P., Schneider, N., Grulke, S., Peters, F., Vila, T., Deby-Dupont, G., Serteyn, D., & Henrotin, Y. (2007). A type II-collagen derived peptide and its nitrated form as new markers of inflammation and cartilage degradation in equine osteochondral lesions. Research in Veterinary Science, 82, 68-75. doi:10.1016/j.rvsc.2006.03.008 |
Henrotin, Y., Addison, S., Kraus, V., & Deberg, M. (2007). Type II collagen markers in osteoarthritis: what do they indicate? Current Opinion in Rheumatology, 19 (5), 444-50. doi:10.1097/BOR.0b013e32829fb3b5 |
Huebner, J., DEBERG, M., Henrotin, Y., & Kraus, V. (2007). Coll2-1 and Coll2-1 NO2: markers of early disease in the Hartley guinea pig model of spontaneous OA. Osteoarthritis and Cartilage, 15 (Suppl C), 70. |
Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2007). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone [Poster presentation]. 27th European Workshop for Rheumatology Research, Barcelona, Spain. |
Sanchez, C., Deberg, M., Msika, P., Baudouin, C., & Henrotin, Y. (2007). Study of the in vitro conditions promoting hypertrophic differentiation of osteoarthritic articular chondrocytes. Osteoarthritis and Cartilage, 15 (Suppl C), 109-S110. |
Sanchez, C., Deberg, M., Msika, P., Baudouin, C., & Henrotin, Y. (2007). Etude des conditions in vitro favorables à la differenciation hypertrophique des chondrocytes articulaires arthrosiques. Revue du Rhumatisme, 74 (10-11), 1085-1086. |
Henrotin, Y., Deberg, M., Crielaard, J.-M., Piccardi, N., Msika, P., & Sanchez, C. (August 2006). Avocado/soybean unsaponifiables prevent the inhibitory effect of osteoarthritic subchondral osteoblasts on aggrecan and type II collagen synthesis by chondrocytes. Journal of Rheumatology, 33 (8), 1668-1678. |
Sanchez, C., Kaut, E., Deberg, M., Delcour, J.-P., & Henrotin, Y. (March 2006). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation. Osteoporosis International, 17 (Suppl. 1), 53. |
Ameye, L., DEBERG, M., Oliviera, M., Labasse, A., Aeschlimann, J., & Henrotin, Y. (2006). C2C and Coll2-1 biomarkers reveal increased type II collagen catabolism in biglycan/fibromodulin double deficient mice. Osteoarthritis and Cartilage, 14 (Suppl B), 61. |
Deberg, M., Labasse, A., Sanchez, C., Quettier, E., Dubuc, J., Bosseloir, A., & Henrotin, Y. (2006). One year follow-up of COLL 2-1, COLL 2-1 NO2 and myeloperoxydase serum levels in osteoarthritic patients after hip or knee replacement. Osteoarthritis and Cartilage, 14 (Suppl B), 18. |
Deberg, M., Labasse, A., Sanchez, C., Quettier, E., Dubuc, J., Bosseloir, A., & Henrotin, Y. (2006). Etude longitudinale de Coll 2-1, Coll 2-1 NO2 et de la myéloperoxydase chez les sujets arthrosiques avant et après la pose d’une prothèse de hanche ou de genou. Revue du Rhumatisme, 73 (10-11), 1032. |
Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Phenotypic characterisation of osteoblasts from the sclerotic zone of human osteoarthritic subchondral bone. Osteoarthritis and Cartilage, 14 (Suppl B), 75. |
Sanchez, C., Deberg, M., Bellahcene, A., Castronovo, V., Msika, P., & Henrotin, Y. (2006). Caractérisation du phénotype des ostéoblastes issus des zones sclérosées de l’os sous-chondral arthrosique humain. Revue du Rhumatisme, 73 (10-11), 1058. |
Sanchez, C., Kaut, E., DEBERG, M., & Henrotin, Y. (2006). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation [Paper presentation]. 6th International Cartilage Repair Society (ICRS) Symposium, San Diego, United States - California. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (November 2005). Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 13 (11), 988-997. doi:10.1016/j.joca.2005.07.012 |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (November 2005). Osteoblasts from the sclerotic subchondral bone downregulate aggrecan but upregulate metalloproteinases expression by chondrocytes. This effect is mimicked by interleukin-6, -1 beta and oncostatin M pre-treated non-sclerotic osteoblasts. Osteoarthritis and Cartilage, 13 (11), 979-987. doi:10.1016/j.joca.2005.03.008 |
Deberg, M., Labasse, A., Christgau, S., Cloos, P., Bang Henriksen, D., Chapelle, J.-P., Zegels, B., Reginster, J.-Y., & Henrotin, Y. (March 2005). New serum biochemical markers (Coll 2-1 and Coll 2-1 NO2) for studying oxidative-related type II collagen network degradation in patients with osteoarthritis and rheumatoid arthritis. Osteoarthritis and Cartilage, 13 (3), 258-265. doi:10.1016/j.joca.2004.12.002 |
Deberg, M., Labasse, A., Collette, J., Seidel, L., Reginster, J.-Y., & Henrotin, Y. (2005). One-year increase of Coll 2-1, a new marker of type II collagen degradation, in urine is highly predictive of radiological OA progression. Osteoarthritis and Cartilage, 13 (12), 1059-65. doi:10.1016/j.joca.2005.06.014 |
Henrotin, Y., Kaut, E., Deberg, M., Delcour, J.-P., & Sanchez, C. (2005). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation [Poster presentation]. 10th World Congress of the OsteoArthritis Research Society International (OARSI), Boston, United States - Massachusetts. |
Henrotin, Y., Kaut, E., Deberg, M., Delcour, J.-P., & Sanchez, C. (2005). Etude in vitro de l’axe physiopathologique os-cartilage dans l’arthrose : implication de l’interleukin-6 [Poster presentation]. 18e Congrès Français de Rhumatologie, Paris, France. |
Henrotin, Y., Kaut, E., Deberg, M., Delcour, J.-P., & Sanchez, C. (2005). Etude in vitro de l’axe physiopathologique os-cartilage dans l’arthrose : implication de l’interleukin-6. Revue du Rhumatisme, 72 (10-11), 958-986. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). P228. Subchondral Bone Osteoblasts Induce Phenotypic Changes in Human Osteoarthritic Chondrocytes. Osteoporosis International, 16 (Suppl.3), 55-56. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). Interleukin-1, Interleukin-6 and Oncostatin M Stimulate Normal Subchondral Osteoblasts to Induce Cartilage Degradation. Osteoporosis International, 16 (Suppl 3), 54-S55. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). Interleukin-1, Interleukin-6 and Oncostatin M Stimulate Normal Subchondral Osteoblasts to Induce Cartilage Degradation [Poster presentation]. 5th European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO 5), Roma, Italy. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2005). Avocado/soybean unsaponifiables prevent osteoarthritic subchondral osteoblasts-induced cartilage degradation. Osteoporosis International, 16 (Suppl.3), 56. |
Sanchez, C., Kaut, E., Deberg, M., & Henrotin, Y. (2005). Interleukin-6 mediates subchondral osteoblasts-induced cartilage degradation. Osteoarthritis and Cartilage, 13 (Suppl A), 157. |
Sanchez, C., Deberg, M., Devel, P., Reginster, J.-Y., Henrotin, Y., & Burton, S. (October 2004). Differential Regulation of Chondrocyte Metabolism by Oncostatin M and Interleukin-6. Osteoarthritis and Cartilage, 12 (10), 801-10. doi:10.1016/j.joca.2004.06.011 |
Henrotin, Y., Deberg, M., Dubuc, J. E., Quettier, E., Christgau, S., & Reginster, J.-Y. (2004). Type II collagen peptides for measuring cartilage degradation. Biorheology, 41 (3-4), 543-547. |
Mathy, M., Devel, P., Sanchez, C., Deberg, M., Deby, G., & Henrotin, Y. (2004). Effects of Interleukin-1beta and Dexamethasone on the Expression by Chondrocytes of Antioxidant Enzymes [Poster presentation]. 9th World Congress of the OsteoArthritis Research Society International (OARSI), Chicago, United States - Illinois. |
Mathy, M., Devel, P., Sanchez, C., Deberg, M., Deby, G., & Henrotin, Y. (2004). Effects of interleukin-1 beta and dexamethasone on the expression by chondrocytes of antioxidant enzymes. Osteoarthritis and Cartilage, 12 (Suppl. B), 51-S52. |
Sanchez, C., Deberg, M., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2004). Régulation du Métabolisme des Chondrocytes par l'Oncostatine M et l'Interleukine 6 [Poster presentation]. 17e Congrès Français de Rhumatologie, Paris, France. |
Sanchez, C., Deberg, M., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2004). Régulation du Métabolisme des Chondrocytes par l'Oncostatine M et l'Interleukine 6. Revue du Rhumatisme, 71 (10-11), 1008. |
Sanchez, C., Deberg, M., Mathy, M., Devel, P., Reginster, J.-Y., & Henrotin, Y. (2004). Etude de l’influence des ostéoblastes sous-chondraux sur l’initiation de la différenciation hypertrophique des chondrocytes humains. Revue du Rhumatisme, 71 (10-11), 917-918. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Subchondral Bone Osteoblasts Induce Phenotypic Changes in Human Osteoarthritic Chondrocytes [Poster presentation]. 9th World Congress of the OsteoArthritis Research Society International (OARSI), Chicago, United States - Illinois. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Subchondral bone osteoblasts induce phenotypic changes in human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 12 (Suppl. B), 99-S100. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Les ostéoblastes arthrosiques inhibent la synthèse d’agrécane et stimulent la production de métalloprotéases par les chondrocytes humains. Revue du Rhumatisme, 71 (10-11), 917. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Interleukin-1, interleukin-6 and oncostatin M stimulate normal subchondral osteoblasts to induce cartilage degradation. Osteoarthritis and Cartilage, 12 (Suppl. B), 98. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Furanic avocado/soybean unsaponifiables prevent osteoarthritic subchondral osteoblasts-induced cartilage degradation. Osteoarthritis and Cartilage, 12 (Suppl. B), 108-S109. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2004). Furanic Avocado/Soybean Unsaponifiables Prevent Osteoarthritic Subchondral Osteoblasts- Induced Cartilage Degradation [Poster presentation]. 9th World Congress of the OsteoArthritis Research Society International (OARSI), Chicago, United States - Illinois. |
Deberg, M., Labasse, A., Christgau, S., Henriksen, D. B., Zegels, B., & Reginster, J.-Y. (November 2003). Cartilage degradation and oxidative damage in OA and RA patients. Osteoporosis International, 14 (Suppl. 7), 44-45. |
Henrotin, Y., Deberg, M., Labasse, A., Collette, J., Christgau, S., Henriksen, D. B., Seidel, L., Rovati, L. C., & Reginster, J.-Y. (November 2003). One-year increase of Coll 2-1 level in urine is predictive of OA progression. Osteoporosis International, 14 (Suppl. 7), 12. |
Deberg, M., Labasse, A., Christgau, S., Henriksen, D., Reginster, J.-Y., & Henrotin, Y. (October 2003). Cartilage degradation and oxidative damage in osteoarthritic and rheumatoid arthritic patients. Osteoarthritis and Cartilage, 11 (Suppl.1), 15. |
Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, G. B., Msika, P., & Reginster, J.-Y. (August 2003). Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and proinflammatory mediator production by human osteoarthritic chondrocytes. Journal of Rheumatology, 30 (8), 1825-1834. |
Sanchez, C., Mathy-Hartert, M., Deberg, M., Ficheux, H., Reginster, J.-Y., & Henrotin, Y. (01 February 2003). Effects of rhein on human articular chondrocytes in alginate beads. Biochemical Pharmacology, 65 (3), 377-388. doi:10.1016/S0006-2952(02)01485-5 |
Deberg, M., Christgau, S., Cloos, P., Henriksen, D. B., Sanchez, C., Labasse, A., Reginster, J.-Y., & Henrotin, Y. (November 2002). Development of new immunoassays for the quantification of inflammatory related cartilage degradation. Osteoporosis International, 13 (Suppl. 3), 54. |
Deberg, M., Christgau, S., Henriksen, D. B., Seidel, L., & Reginster, J.-Y. (November 2002). High levels of the type II collagen peptide (COLL 2-1) in serum is predictive of the radiological progressin of knee osteoarthritis. Osteoporosis International, 13 (Suppl.3), 53-54. |
Deberg, M., Christgau, S., Henriksen, D. B., Seidel, L., Reginster, J.-Y., & Henrotin, Y. (November 2002). The urinary levels of type II collagen peptide COLL 2-1 and its nitrated form (COLL 2-1 NO2) are correlated with the clinical severity of knee osteoarthritis. Osteoporosis International, 13 (Suppl.3), 54. |
Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Miska, P., & Reginster, J.-Y. (November 2002). Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and pro-inflammatory mediators production by human osteoarthritic chondrocytes. Osteoporosis International, 13 (Suppl.3), 53. |
Henrotin, Y., Sanchez, C., Mathy-Hartert, M., Deberg, M., & Reginster, J.-Y. (November 2002). Characterization of the metabolism of osteoarthritic chondrocytes cultured in alginate beads. Osteoporosis International, 13 (Suppl. 3), 52. |
Deberg, M., Christgau, S., Henriksen, D., Cloos, P., COLLETTE, J., Reginster, J.-Y., & Henrotin, Y. (September 2002). Development of new immunoassays for the quantification of inflammatory related cartilage degradation. Arthritis and Rheumatism, 46 (number 9 (suppl.)), 496. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2002). Avocado/soybean unsaponifiables increase aggrecan synthesis and reduce catabolic and pro-inflammatory mediators production by human osteoarthritic chondrocytes. Osteoarthritis and Cartilage, 10 (Suppl A), 34. |
Sanchez, C., Deberg, M., Piccardi, N., Msika, P., Reginster, J.-Y., & Henrotin, Y. (2002). Avocado/soybean Unsaponifiables Increase Aggrecan Synthesis and Reduce Catabolic and Pro-inflammatory Mediators Production by Human Osteoarthritic Chondrocytes. Arthritis and Rheumatism, 47, 50-58. |
Sanchez, C., Mathy, M., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2002). Characterization of the Metabolism of Osteoarthritic Chondrocytes Cultured in Alginate Beads. Osteoarthritis and Cartilage, 10 (SA), 34. |
Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, B., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Tissue Engineering, 7 (5), 648. |
Henrotin, Y., Sanchez, C., Deberg, M., Piccardi, N., Guillou, B., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Osteoarthritis and Cartilage, 9 (supplB), 25. |
Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Long-term effects of nonsteroidal antiinflammatory drugs on human chrondrocytes in alginate beads. Tissue Engineering, 7 (5), 648. |
Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Long-term Effects of Avocado/Soybean Unsaponifiable on Human Chondrocytes Metabolism. Clinical Rheumatology, 20 (5), 45. |
Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads [Poster presentation]. First Biennal Meeting of the European Tissue Engineering Society International (ETES), Freiburg, Germany. |
Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads. Clinical Rheumatology, 20 (5), 414. |
Henrotin, Y., Sanchez, C., Deberg, M., & Reginster, J.-Y. (2001). Diacerein by its Metabolite Rhein, Down-Regulates Stromelysins and Nitric Oxide Productions and Up-Regulates Aggrecan Production by Human Chondrocytes in Alginate Beads. Tissue Engineering, 7 (5), 648. |
Sanchez, C., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Annals of the Rheumatic Diseases, 60 (suppl1), 284. |
Sanchez, C., Deberg, M., Reginster, J.-Y., & Henrotin, Y. (2001). Long-term Effects of Nonsteroidal Antiinflammatory Drugs on Human Chondrocytes in Alginate Beads. Osteoarthritis and Cartilage, 9 (supplB), 32. |
Deberg, M., Houssa, P., Frank, B. H., Sodoyez-Goffaux, F., & Sodoyez, J. C. (July 1998). Highly Specific Radioimmunoassay for Human Insulin Based on Immune Exclusion of All Insulin Precursors. Clinical Chemistry, 44 (7), 1504-13. doi:10.1093/clinchem/44.7.1504 |
Houssa, P., Dinesen, B., Deberg, M., Frank, B. H., Van Schravendijk, C., Sodoyez-Goffaux, F., & Sodoyez, J. C. (July 1998). First Direct Assay for Intact Human Proinsulin. Clinical Chemistry, 44 (7), 1514-9. doi:10.1093/clinchem/44.7.1514 |